nach oben

Reactions Weekly

Erschienen in:

01.06.2023 | Case report

Luspatercept

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated.

Manganas KM, et al. THE USE OF LUSPATERCEPT IN PATIENTS WITH B -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT'S EXPERIENCE. HemaSphere 7 (Suppl. 1): 15-16 (plus poster) abstr. 5610224, Apr 2023. Available from: URL: http://doi.org/10.1097/01.HS9.0000928240.02267.88 [abstract]

Titel: Luspatercept
Lack of efficacy: case report
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41914-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Multiple drugs

Rituximab

Apremilast

Tramadol warnings and precautions updated

Lenalidomide

Antibacterials